<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00784953</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-RTW-SYM-2008/1</org_study_id>
    <nct_id>NCT00784953</nct_id>
  </id_info>
  <brief_title>Real Life Effectiveness in Patients With Not Optimally Controlled Asthma</brief_title>
  <official_title>Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-interventional study to explore actual asthma control status in real-life environment
      and to observe the efficacy after stepped-up to Symbicort SMART or various identical
      regimens.

      The study will be implemented by screening asthmatic patients from respiratory clinics to
      identify those not optimally controlled and required stepping up the controllers to initiate,
      or to titrate dose of, ICS/LABA including Symbicort.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ACQ score from baseline to the mean of all available data from the follow up visits</measure>
    <time_frame>wk 4±1; wk 12~16</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the individual asthma control status &amp; pulmonary function from enrollment</measure>
    <time_frame>wk 4±1; wk 12~16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose/usage of ICS/LABA and relievers &amp; Patient compliance</measure>
    <time_frame>wk 4±1; wk 12~16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical resource utilization</measure>
    <time_frame>wk 4±1; wk 12~16; 6 month; 12 month</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">842</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Asthma patients who were partly controlled or uncontrolled, need to step up, or adjust dose of the controller medications to ICS/LABA</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Medical center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma patient who was partly controlled or uncontrolled by previous controllers of
             ICS only, or low dose ICS plus either LABA, leukotriene modifier or theophylline; or
             ICS- naïve with severe and persist symptom based on physician's judgment

          -  According to GINA guideline, who need to step up the controller medications, and
             ICS/LABA to be prescribed based on physician's discretion

        Exclusion Criteria:

          -  Patients aged not within limitation refer to label information of various product
             prescribed

          -  Patients who have taken oral corticosteroids within 4 weeks prior to enrollment

          -  Patients with contraindications to prescribed medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robin Meng, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca Taiwan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jia-Horng Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Changhua</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Keelung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&amp;studyid=1082&amp;filename=CSR-NIS-RTW-SYM-2008-1.pdf</url>
    <description>CSR Synopsis</description>
  </link>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2008</study_first_submitted>
  <study_first_submitted_qc>November 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2008</study_first_posted>
  <last_update_submitted>November 9, 2015</last_update_submitted>
  <last_update_submitted_qc>November 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Symbicort SMART</keyword>
  <keyword>budesonide</keyword>
  <keyword>formoterol</keyword>
  <keyword>ICS/LABA</keyword>
  <keyword>Asthma Control Questionnaire</keyword>
  <keyword>Not optimally controlled asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

